DR. Charles Seehorn, MD is a rheumatology internal medicine in Charlotte, NC. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Charles Seehorn, MD NPI is 1528013109. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
1918 RANDOLPH RD
STE 600
CHARLOTTE, NC
ZIP 28207-100
Phone: (704) 342-0252
Fax: (704) 342-1853
The NPI 1528013109 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
- Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85025)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Injection of different drug or substance into a vein for therapy, diagnosis, or prevention (HCPCS:96375)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour (HCPCS:96365)
- Bone density measurement using dedicated x-ray machine (HCPCS:77080)
- Aspiration and/or injection of large joint or joint capsule (HCPCS:20610)
- Automated urinalysis test (HCPCS:81003)
- X-ray of hip with pelvis, 2-3 views (HCPCS:73502)
The enumeration date for this NPI number is 5/23/2006 and was last updated on 9/30/2022.